
### [MONDO:0017024](http://purl.obolibrary.org/obo/MONDO_0017024)
**Label:** secondary interstitial lung disease specific to childhood associated with a metabolic disease

**Subclasses:** [MONDO:0018458](http://purl.obolibrary.org/obo/MONDO_0018458) (familial hypocalciuric hypercalcemia), [MONDO:0016501](http://purl.obolibrary.org/obo/MONDO_0016501) (Hermansky-Pudlak syndrome with pulmonary fibrosis), 

**Corr. equiv. classes:** [Orphanet:405](http://www.orpha.net/ORDO/Orphanet_405), [Orphanet:231500](http://www.orpha.net/ORDO/Orphanet_231500), 

**Class expressions from DL-Learner:**

- [HP:0012609](http://purl.obolibrary.org/obo/HP_0012609) (Hypomagnesiuria) 75.00%
- [HP:0003529](http://purl.obolibrary.org/obo/HP_0003529) (Parathormone-independent increased renal tubular calcium reabsorption) 75.00%
- [HP:0003513](http://purl.obolibrary.org/obo/HP_0003513) (Reduced ratio of renal calcium clearance to creatinine clearance) 75.00%
- [HP:0003127](http://purl.obolibrary.org/obo/HP_0003127) (Hypocalciuria) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0200013](http://purl.obolibrary.org/obo/HP_0200013) (Neoplasm of fatty tissue) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0040077](http://purl.obolibrary.org/obo/HP_0040077) (Abnormal concentration of calcium in blood) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012609](http://purl.obolibrary.org/obo/HP_0012609) (Hypomagnesiuria) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012607](http://purl.obolibrary.org/obo/HP_0012607) (Abnormal urine magnesium concentration) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012091](http://purl.obolibrary.org/obo/HP_0012091) (Abnormality of pancreas physiology) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012032](http://purl.obolibrary.org/obo/HP_0012032) (Lipoma) 75.00%
- [HP:0008732](http://purl.obolibrary.org/obo/HP_0008732) (Renal hypophosphatemia) and [HP:0012031](http://purl.obolibrary.org/obo/HP_0012031) (Lipomatous tumor) 75.00%


